Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
IgA nephropathy
2023 Standout
Works of C. Mata being referenced
Insulin resistance in hidradenitis suppurativa: a case–control study
2018
Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study.
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| C. Mata | 109 | 129 | 24 | 69 | 15 | 291 | |
| Claudio Comacchi | 134 | 154 | 81 | 29 | 18 | 291 | |
| Ferguson Rh | 169 | 154 | 58 | 44 | 11 | 320 | |
| Kurtuluş Didem Yazganoğlu | 72 | 90 | 50 | 41 | 22 | 313 | |
| Nagui Gendi | 157 | 104 | 67 | 95 | 16 | 294 | |
| J L Dupond | 187 | 125 | 43 | 63 | 15 | 296 | |
| Farrell | 113 | 30 | 72 | 69 | 15 | 269 | |
| M. Carmen Gonzalez-Vela | 96 | 88 | 51 | 44 | 16 | 283 | |
| Marcia Friedman | 71 | 58 | 48 | 29 | 18 | 303 | |
| Josep Maria Llobet | 116 | 46 | 59 | 45 | 18 | 321 | |
| C. Bélizna | 153 | 50 | 25 | 50 | 16 | 334 |
All Works
Login with ORCID to disown or claim papers
Loading papers...